IL-23 acts as a stimulator and regulator for activating pathogenic Th17 lymphocytes, which induces hypertension only in SS rats through increasing the population of CD4+IL-17A+ (Th17) cells and the level of serum IL-17A (Fig. 7). Here, IL17A is linked to hypertensive disorder.